RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Signaling Pathway of Lysophosphatidic Acid-Induced Contraction in Feline Esophageal Smooth Muscle Cells

      한글로보기

      https://www.riss.kr/link?id=A103914098

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Lysolipids such as LPA, S1P and SPC have diverse biological activities including cell proliferation,differentiation, and migration. We investigated signaling pathways of LPA-induced contraction in feline esophageal smooth muscle cells. We used freshly isolated smooth muscle cells and permeabilized cells from cat esophagus to measure the length of cells. Maximal contraction occurred at 10−6 M and the response peaked at 30s. To identify LPA receptor subtypes in cells, western blot analysis was performed with antibodies to LPA receptor subtypes. LPA1 and LPA3 receptor were detected at 50 kDa and 44kDa. LPA-induced contraction was almost completely blocked by LPA receptor (1/3) antagonist KI16425. Pertussis toxin (PTX) inhibited the contraction induced by LPA, suggesting that the contraction is mediated by a PTX-sensitive G protein. Phospholipase C (PLC) inhibitors U73122 and neomycin, and protein kinase C (PKC) inhibitor GF109203X also reduced the contraction. The PKC-mediated contraction may be isozyme-specific since only PKCε antibody inhibited the contraction.
      MEK inhibitor PD98059 and JNK inhibitor SP600125 blocked the contraction. However, there is no synergistic effect of PKC and MAPK on the LPA-induced contraction. In addition, RhoA inhibitor C3exoenzyme and ROCK inhibitor Y27632 significantly, but not completely, reduced the contraction. The present study demonstrated that LPA-induced contraction seems to be mediated by LPA receptors (1/3),coupled to PTX-sensitive G protein, resulting in activation of PLC, PKC-ε pathway, which subsequently mediates activation of ERK and JNK. The data also suggest that RhoA/ROCK are involved in the LPA-induced contraction.
      번역하기

      Lysolipids such as LPA, S1P and SPC have diverse biological activities including cell proliferation,differentiation, and migration. We investigated signaling pathways of LPA-induced contraction in feline esophageal smooth muscle cells. We used freshly...

      Lysolipids such as LPA, S1P and SPC have diverse biological activities including cell proliferation,differentiation, and migration. We investigated signaling pathways of LPA-induced contraction in feline esophageal smooth muscle cells. We used freshly isolated smooth muscle cells and permeabilized cells from cat esophagus to measure the length of cells. Maximal contraction occurred at 10−6 M and the response peaked at 30s. To identify LPA receptor subtypes in cells, western blot analysis was performed with antibodies to LPA receptor subtypes. LPA1 and LPA3 receptor were detected at 50 kDa and 44kDa. LPA-induced contraction was almost completely blocked by LPA receptor (1/3) antagonist KI16425. Pertussis toxin (PTX) inhibited the contraction induced by LPA, suggesting that the contraction is mediated by a PTX-sensitive G protein. Phospholipase C (PLC) inhibitors U73122 and neomycin, and protein kinase C (PKC) inhibitor GF109203X also reduced the contraction. The PKC-mediated contraction may be isozyme-specific since only PKCε antibody inhibited the contraction.
      MEK inhibitor PD98059 and JNK inhibitor SP600125 blocked the contraction. However, there is no synergistic effect of PKC and MAPK on the LPA-induced contraction. In addition, RhoA inhibitor C3exoenzyme and ROCK inhibitor Y27632 significantly, but not completely, reduced the contraction. The present study demonstrated that LPA-induced contraction seems to be mediated by LPA receptors (1/3),coupled to PTX-sensitive G protein, resulting in activation of PLC, PKC-ε pathway, which subsequently mediates activation of ERK and JNK. The data also suggest that RhoA/ROCK are involved in the LPA-induced contraction.

      더보기

      참고문헌 (Reference)

      1 Gong MC, "Translocation of rhoA associated with Ca2+ sensitization of smooth muscle" 272 : 10704-10709, 1997

      2 Shin CY, "The signal transduction of endothelin-1-induced circular smooth muscle cell contraction in cat esophagus" AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS 302 : 924-934, 2002

      3 Yang SJ, "The mechanism of contraction by 2-chloroadenosine in cat detrusor muscle cells" 163 : 652-658, 2000

      4 Yong Sung Kim, "The Signaling Mechanism of the Sphingosylphosphorylcholine-induced Contraction in Cat Esophageal Smooth Muscle Cells" 대한약학회 30 (30): 1608-1618, 2007

      5 Tokumura A, "Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregant rats" 245 : 74-83, 1980

      6 Bischoff A, "Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro" 130 : 1871-1877, 2000

      7 Ohmori T, "Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2" 58 : 170-177, 2003

      8 Parrill AL, "Sphingosine 1-phosphate and lysophosphatidic acid receptors: agonist and antagonist binding and progress toward development of receptor-specific ligands" 15 : 467-476, 2004

      9 Hyun Ju Song, "Sphingosine 1-Phosphate-induced Signal Transduction in Cat Esophagus Smooth Muscle Cells" 한국분자세포생물학회 21 (21): 42-51, 2006

      10 Shirai H, "Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling" 16 : 111-115, 2007

      1 Gong MC, "Translocation of rhoA associated with Ca2+ sensitization of smooth muscle" 272 : 10704-10709, 1997

      2 Shin CY, "The signal transduction of endothelin-1-induced circular smooth muscle cell contraction in cat esophagus" AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS 302 : 924-934, 2002

      3 Yang SJ, "The mechanism of contraction by 2-chloroadenosine in cat detrusor muscle cells" 163 : 652-658, 2000

      4 Yong Sung Kim, "The Signaling Mechanism of the Sphingosylphosphorylcholine-induced Contraction in Cat Esophageal Smooth Muscle Cells" 대한약학회 30 (30): 1608-1618, 2007

      5 Tokumura A, "Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregant rats" 245 : 74-83, 1980

      6 Bischoff A, "Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro" 130 : 1871-1877, 2000

      7 Ohmori T, "Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2" 58 : 170-177, 2003

      8 Parrill AL, "Sphingosine 1-phosphate and lysophosphatidic acid receptors: agonist and antagonist binding and progress toward development of receptor-specific ligands" 15 : 467-476, 2004

      9 Hyun Ju Song, "Sphingosine 1-Phosphate-induced Signal Transduction in Cat Esophagus Smooth Muscle Cells" 한국분자세포생물학회 21 (21): 42-51, 2006

      10 Shirai H, "Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling" 16 : 111-115, 2007

      11 Ma T, "Signal pathways involved in emodin-induced contraction of smooth muscle cells from rat colon" 10 : 1476-1479, 2004

      12 Bennett BL, "SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase" 98 : 13681-13686, 2001

      13 Olofsson B, "Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling" 11 : 545-554, 1999

      14 Tangkijvanich P, "Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration" 10 : 352-358, 2003

      15 Wang P, "Rho a regulates sustained smooth muscle contraction through cytoskeletal reorganization of HSP27" 275 : G1454-G1462, 1998

      16 Bitar KN, "Regulation of smooth muscle contraction in rabbit internal anal sphincter by protein kinase C and Ins(1,4,5)P3" 260 : G537-G542, 1991

      17 Nishizuka Y, "Protein kinase C and lipid signaling for sustained cellular responses" 9 : 484-496, 1995

      18 Violin JD, "Pathway illuminated: visualizing protein kinase C signaling" 55 : 653-660, 2003

      19 Kostenis E, "Novel clusters of receptors for sphingosine-1- phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for “old” ligands" 92 : 923-936, 2004

      20 Meyer zu Heringdorf D, "Molecular diversity of sphingolipid signalling" 410 : 34-38, 1997

      21 Cao W, "MAPK mediates PKC-dependent contraction of cat esophageal and lower esophageal sphincter circular smooth muscle" 285 : G86-G95, 2003

      22 Ishii I, "Lysophospholipid receptors: signaling and biology" 73 : 321-354, 2004

      23 Fukushima N, "Lysophospholipid receptors" 41 : 507-534, 2001

      24 정승수, "Lysophosphatidylcholine Increases Ca²+ Current via Activation of Protein Kinase C in Rabbit Portal Vein Smooth Muscle Cells" 대한약리학회 12 (12): 31-35, 2008

      25 Moolenaar WH, "Lysophosphatidic acid: G-protein signalling and cellular responses" 9 : 168-173, 1997

      26 Renbäck K, "Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice" 270 : 59-61, 1999

      27 Howe LR, "Lysophosphatidic acid stimulates mitogen- activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1" 268 : 20717-20720, 1993

      28 Contos JJ, "Lysophosphatidic acid receptors" 58 : 1188-1196, 2000

      29 Toews ML, "Lysophosphatidic acid enhances contractility of isolated airway smooth muscle" 83 : 1216-1222, 1997

      30 Ohta H, "Ki16425, a subtypeselective antagonist for EDG-family lysophosphatidic acid receptors" 64 : 994-1005, 2003

      31 Chun J, "International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature" 54 : 265-269, 2002

      32 Payne DM, "Identification of the regulatory phosphorylation sites in pp42/mitogenactivated protein kinase (MAP kinase)" 10 : 885-892, 1991

      33 van der Bend RL, "Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid" 11 : 2495-2501, 1992

      34 Cobb MH, "How MAP kinases are regulated" 270 : 14843-14846, 1995

      35 Radeff-Huang J, "G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival" 92 : 949-966, 2004

      36 백인지, "Flavone Attenuates Vascular Contractions by Inhibiting RhoA/Rho Kinase Pathway" 대한약리학회 13 (13): 201-207, 2009

      37 Ando T, "Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma" 15 : 1551-1555, 2006

      38 Dodick DW, "Evaluation and management of asymptomatic carotid artery stenosis" 79 : 937-944, 2004

      39 Van Brocklyn JR, "Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival" 142 : 229-240, 1998

      40 Goetzl EJ, "Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate" 12 : 1589-1598, 1998

      41 Sohn UD, "Different protein kinase C isozymes mediate lower esophageal sphincter tone and phasic contraction of esophageal circular smooth muscle" 51 : 462-470, 1997

      42 Biancani P, "Contraction mediated by Ca2+ influx in esophageal muscle and by Ca2+ release in the LES" 253 : G760-G766, 1987

      43 Chen XQ, "Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies" 277 : 12680-12688, 2002

      44 Patel CA, "Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK" 292 : G1747-G1756, 2007

      45 Fabiato A, "Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells" 75 : 463-505, 1979

      46 Siess W, "Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate" 1582 : 204-215, 2002

      47 Sohn UD, "Agonist- independent, muscle-type-specific signal transduction pathways in cat esophageal and lower esophageal sphincter circular smooth muscle" 273 : 482-491, 1995

      48 van Koppen C, "Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine- 1-phosphate" 271 : 2082-2087, 1996

      49 Fox T, "A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase" 7 : 2249-2255, 1998

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-04-29 학술지명변경 외국어명 : THE KOREAN JOURNAL OF Physiology & Pharmacology -> The Korean Journal of Physiology & Pharmacology KCI등재
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-10-12 학술지명변경 한글명 : 대한 생리.약리학회지 -> The Korean Journal of Physiology & Pharmacology
      외국어명 : THE KOREAN JOURNAL OF Physilogy & Pharmacology -> THE KOREAN JOURNAL OF Physiology & Pharmacology
      KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.85 0.36 1.29
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.05 0.9 0.575 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼